SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis

Intestinal epithelial cells (IECs) constitute a defensive physical barrier in mucosal tissues and their disruption is involved in the etiopathogenesis of several inflammatory pathologies, such as Ulcerative Colitis (UC). Recently, the succinate receptor SUCNR1 was associated with the activation of i...

Full description

Saved in:
Bibliographic Details
Published inBiomedicines Vol. 10; no. 3; p. 532
Main Authors Bauset, Cristina, Lis-Lopez, Lluis, Coll, Sandra, Gisbert-Ferrándiz, Laura, Macias-Ceja, Dulce C., Seco-Cervera, Marta, Navarro, Francisco, Esplugues, Juan V., Calatayud, Sara, Ortiz-Masia, Dolores, Barrachina, Maria D., Cosín-Roger, Jesús
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 24.02.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Intestinal epithelial cells (IECs) constitute a defensive physical barrier in mucosal tissues and their disruption is involved in the etiopathogenesis of several inflammatory pathologies, such as Ulcerative Colitis (UC). Recently, the succinate receptor SUCNR1 was associated with the activation of inflammatory pathways in several cell types, but little is known about its role in IECs. We aimed to analyze the role of SUCNR1 in the inflammasome priming and its relevance in UC. Inflammatory and inflammasome markers and SUCNR1 were analyzed in HT29 cells treated with succinate and/or an inflammatory cocktail and transfected with SUCNR1 siRNA in a murine DSS model, and in intestinal resections from 15 UC and non-IBD patients. Results showed that this receptor mediated the inflammasome, priming both in vitro in HT29 cells and in vivo in a murine chronic DSS-colitis model. Moreover, SUNCR1 was also found to be involved in the activation of the inflammatory pathways NFкB and ERK pathways, even in basal conditions, since the transient knock-down of this receptor significantly reduced the constitutive levels of pERK-1/2 and pNFкB and impaired LPS-induced inflammation. Finally, UC patients showed a significant increase in the expression of SUCNR1 and several inflammasome components which correlated positively and significantly. Therefore, our results demonstrated a role for SUCNR1 in basal and stimulated inflammatory pathways in intestinal epithelial cells and suggested a pivotal role for this receptor in inflammasome activation in UC.
AbstractList Intestinal epithelial cells (IECs) constitute a defensive physical barrier in mucosal tissues and their disruption is involved in the etiopathogenesis of several inflammatory pathologies, such as Ulcerative Colitis (UC). Recently, the succinate receptor SUCNR1 was associated with the activation of inflammatory pathways in several cell types, but little is known about its role in IECs. We aimed to analyze the role of SUCNR1 in the inflammasome priming and its relevance in UC. Inflammatory and inflammasome markers and SUCNR1 were analyzed in HT29 cells treated with succinate and/or an inflammatory cocktail and transfected with SUCNR1 siRNA in a murine DSS model, and in intestinal resections from 15 UC and non-IBD patients. Results showed that this receptor mediated the inflammasome, priming both in vitro in HT29 cells and in vivo in a murine chronic DSS-colitis model. Moreover, SUNCR1 was also found to be involved in the activation of the inflammatory pathways NFкB and ERK pathways, even in basal conditions, since the transient knock-down of this receptor significantly reduced the constitutive levels of pERK-1/2 and pNFкB and impaired LPS-induced inflammation. Finally, UC patients showed a significant increase in the expression of SUCNR1 and several inflammasome components which correlated positively and significantly. Therefore, our results demonstrated a role for SUCNR1 in basal and stimulated inflammatory pathways in intestinal epithelial cells and suggested a pivotal role for this receptor in inflammasome activation in UC.Intestinal epithelial cells (IECs) constitute a defensive physical barrier in mucosal tissues and their disruption is involved in the etiopathogenesis of several inflammatory pathologies, such as Ulcerative Colitis (UC). Recently, the succinate receptor SUCNR1 was associated with the activation of inflammatory pathways in several cell types, but little is known about its role in IECs. We aimed to analyze the role of SUCNR1 in the inflammasome priming and its relevance in UC. Inflammatory and inflammasome markers and SUCNR1 were analyzed in HT29 cells treated with succinate and/or an inflammatory cocktail and transfected with SUCNR1 siRNA in a murine DSS model, and in intestinal resections from 15 UC and non-IBD patients. Results showed that this receptor mediated the inflammasome, priming both in vitro in HT29 cells and in vivo in a murine chronic DSS-colitis model. Moreover, SUNCR1 was also found to be involved in the activation of the inflammatory pathways NFкB and ERK pathways, even in basal conditions, since the transient knock-down of this receptor significantly reduced the constitutive levels of pERK-1/2 and pNFкB and impaired LPS-induced inflammation. Finally, UC patients showed a significant increase in the expression of SUCNR1 and several inflammasome components which correlated positively and significantly. Therefore, our results demonstrated a role for SUCNR1 in basal and stimulated inflammatory pathways in intestinal epithelial cells and suggested a pivotal role for this receptor in inflammasome activation in UC.
Intestinal epithelial cells (IECs) constitute a defensive physical barrier in mucosal tissues and their disruption is involved in the etiopathogenesis of several inflammatory pathologies, such as Ulcerative Colitis (UC). Recently, the succinate receptor SUCNR1 was associated with the activation of inflammatory pathways in several cell types, but little is known about its role in IECs. We aimed to analyze the role of SUCNR1 in the inflammasome priming and its relevance in UC. Inflammatory and inflammasome markers and SUCNR1 were analyzed in HT29 cells treated with succinate and/or an inflammatory cocktail and transfected with SUCNR1 siRNA in a murine DSS model, and in intestinal resections from 15 UC and non-IBD patients. Results showed that this receptor mediated the inflammasome, priming both in vitro in HT29 cells and in vivo in a murine chronic DSS-colitis model. Moreover, SUNCR1 was also found to be involved in the activation of the inflammatory pathways NFкB and ERK pathways, even in basal conditions, since the transient knock-down of this receptor significantly reduced the constitutive levels of pERK-1/2 and pNFкB and impaired LPS-induced inflammation. Finally, UC patients showed a significant increase in the expression of SUCNR1 and several inflammasome components which correlated positively and significantly. Therefore, our results demonstrated a role for SUCNR1 in basal and stimulated inflammatory pathways in intestinal epithelial cells and suggested a pivotal role for this receptor in inflammasome activation in UC.
Author Gisbert-Ferrándiz, Laura
Esplugues, Juan V.
Ortiz-Masia, Dolores
Macias-Ceja, Dulce C.
Barrachina, Maria D.
Seco-Cervera, Marta
Calatayud, Sara
Bauset, Cristina
Coll, Sandra
Navarro, Francisco
Lis-Lopez, Lluis
Cosín-Roger, Jesús
AuthorAffiliation 4 CIBERehd, 28029 Madrid, Spain
1 Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain; cristina.bauset@uv.es (C.B.); lluislis@alumni.uv.es (L.L.-L.); sandra.coll@uv.es (S.C.); laura.gisbert@uv.es (L.G.-F.); macias.dcc@gmail.com (D.C.M.-C.); juan.v.esplugues@uv.es (J.V.E.); sara.calatayud@uv.es (S.C.); dolores.barrachina@uv.es (M.D.B.)
2 Hospital Dr. Peset, FISABIO, 46017 Valencia, Spain; marta.seco@uv.es
5 Departamento de Medicina, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain
3 Hospital de Manises, 46940 Valencia, Spain; fran.navarro.vicente@gmail.com
AuthorAffiliation_xml – name: 4 CIBERehd, 28029 Madrid, Spain
– name: 1 Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain; cristina.bauset@uv.es (C.B.); lluislis@alumni.uv.es (L.L.-L.); sandra.coll@uv.es (S.C.); laura.gisbert@uv.es (L.G.-F.); macias.dcc@gmail.com (D.C.M.-C.); juan.v.esplugues@uv.es (J.V.E.); sara.calatayud@uv.es (S.C.); dolores.barrachina@uv.es (M.D.B.)
– name: 3 Hospital de Manises, 46940 Valencia, Spain; fran.navarro.vicente@gmail.com
– name: 5 Departamento de Medicina, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain
– name: 2 Hospital Dr. Peset, FISABIO, 46017 Valencia, Spain; marta.seco@uv.es
Author_xml – sequence: 1
  givenname: Cristina
  surname: Bauset
  fullname: Bauset, Cristina
– sequence: 2
  givenname: Lluis
  surname: Lis-Lopez
  fullname: Lis-Lopez, Lluis
– sequence: 3
  givenname: Sandra
  surname: Coll
  fullname: Coll, Sandra
– sequence: 4
  givenname: Laura
  orcidid: 0000-0002-2007-8716
  surname: Gisbert-Ferrándiz
  fullname: Gisbert-Ferrándiz, Laura
– sequence: 5
  givenname: Dulce C.
  surname: Macias-Ceja
  fullname: Macias-Ceja, Dulce C.
– sequence: 6
  givenname: Marta
  orcidid: 0000-0002-4278-2835
  surname: Seco-Cervera
  fullname: Seco-Cervera, Marta
– sequence: 7
  givenname: Francisco
  orcidid: 0000-0002-9775-3169
  surname: Navarro
  fullname: Navarro, Francisco
– sequence: 8
  givenname: Juan V.
  surname: Esplugues
  fullname: Esplugues, Juan V.
– sequence: 9
  givenname: Sara
  orcidid: 0000-0001-9675-2423
  surname: Calatayud
  fullname: Calatayud, Sara
– sequence: 10
  givenname: Dolores
  orcidid: 0000-0002-7924-9962
  surname: Ortiz-Masia
  fullname: Ortiz-Masia, Dolores
– sequence: 11
  givenname: Maria D.
  surname: Barrachina
  fullname: Barrachina, Maria D.
– sequence: 12
  givenname: Jesús
  surname: Cosín-Roger
  fullname: Cosín-Roger, Jesús
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35327334$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1r3DAQhk1JaNI0_6AUQy-9bKNPy86hUEzaLqQfJN2zkOXxRossbSztQv99J7tpSEKpLjMaPfNqZqRXxUGIAYriDSUfOG_IWefiCL2zLkCihHAiOXtRHDPG1Kwhsjl45B8VpymtCK6G8pqKl8URR1xxLo6LfL1ov1_R8huqmQypzDdQ_pzc6MKyvM6wLuOwi83D4M04moQXly7gHunsgvHlxdoh4R26LXifzssr8LA1we7Ihbcwmey2ULbRu-zS6-JwMD7B6b09KRafL361X2eXP77M20-XMysJyzNWQ60qKQQZ6kZaqXqlOOWml7QasGVlDLe0J1BR6ClhTKhKWOCU0UGh5SfFfK_bR7PSa-zKTL91NE7vAnFaajNlZz1owq3oemtroExYI7uu4rwXBvUFZ2JArY97rfWmw9FbCHky_ono05PgbvQybnXdCEklQYH39wJTvN3g7PToksV5mQBxkzSrsFFGacMQffcMXcXNhKPeUYwLxQVF6u3jih5K-fu4CIg9YKeY0gTDA0KJvvtG-l_fCNPOn6VZl_H94l1fzv8_-Q-edNEV
CitedBy_id crossref_primary_10_3390_cancers15102862
crossref_primary_10_3390_biomedicines11051428
crossref_primary_10_3390_ijms241612936
crossref_primary_10_3390_ijms26072855
crossref_primary_10_1080_07391102_2024_2440651
crossref_primary_10_1016_j_mucimm_2022_11_001
crossref_primary_10_1080_19490976_2024_2341457
crossref_primary_10_3389_fendo_2023_1197102
crossref_primary_10_1007_s10753_025_02290_9
crossref_primary_10_3390_ijms242015256
Cites_doi 10.1371/journal.pone.0119179
10.3389/fimmu.2019.00276
10.1038/s41385-018-0087-3
10.1111/cen.14289
10.3390/cells9071647
10.1016/j.micinf.2015.10.007
10.1038/s41590-019-0372-7
10.1002/path.4357
10.1096/fj.202002622R
10.1096/fj.201800285
10.1038/s41419-018-0708-5
10.1167/iovs.10-6722
10.1016/j.immuni.2009.02.005
10.1038/mi.2013.13
10.1038/nrgastro.2015.186
10.1016/j.tcb.2013.11.008
10.1038/srep39075
10.1016/j.immuni.2010.02.012
10.1093/ecco-jcc/jjaa022
10.1053/j.gastro.2020.08.029
10.1016/j.it.2020.11.004
10.2147/JIR.S141220
10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7
10.1016/j.molmet.2017.09.005
10.3390/cancers13071653
10.3390/cells8091078
10.1096/fj.202001037R
10.3390/cells9051104
10.18632/oncotarget.14485
10.1371/journal.pone.0074010
10.1016/j.immuni.2010.03.003
10.1084/jem.20100050
10.1111/imr.12296
10.1084/jem.20160061
10.1016/S0140-6736(17)32448-0
10.1016/j.molmed.2016.12.007
10.1136/gut.2009.197822
10.1046/j.1365-2249.1999.00878.x
10.3803/EnM.2020.35.1.36
10.1038/ki.2009.360
10.2337/db14-0346
10.1111/all.13005
10.1007/s10753-019-01008-y
10.1038/mi.2014.1
10.1002/JLB.3MR0720-472RR
10.1002/ibd.21478
10.3390/proteomes6020017
10.1007/s00125-017-4261-z
10.3389/fcell.2020.00661
10.1038/mi.2015.123
10.1021/acs.jmedchem.0c01020
10.3748/wjg.v26.i28.3998
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
NPM
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/biomedicines10030532
DatabaseName CrossRef
PubMed
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


PubMed
Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2227-9059
ExternalDocumentID oai_doaj_org_article_03c4bdcc8e124ca5bb633d4ac1d4324f
PMC8945150
35327334
10_3390_biomedicines10030532
Genre Journal Article
GeographicLocations United States--US
Spain
GeographicLocations_xml – name: Spain
– name: United States--US
GrantInformation_xml – fundername: Ministerio de Ciencia e Innovación
  grantid: PID2019-108996RB-I00
– fundername: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
  grantid: UGP-19-032
– fundername: Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
  grantid: EHD19PI05
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
AAYXX
ACPRK
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CITATION
EMOBN
GROUPED_DOAJ
GX1
HCIFZ
HYE
IAO
IHR
INH
ITC
KQ8
LK8
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PROAC
RPM
NPM
ABUWG
AZQEC
DWQXO
GNUQQ
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c502t-28e8765440f895c57d77313ad516f3057aa3c1d0e61ed10224764ce3121f7ce33
IEDL.DBID DOA
ISSN 2227-9059
IngestDate Wed Aug 27 01:13:59 EDT 2025
Thu Aug 21 18:12:54 EDT 2025
Tue Aug 05 11:31:03 EDT 2025
Fri Jul 25 12:13:07 EDT 2025
Thu Jan 02 22:55:36 EST 2025
Thu Apr 24 22:54:33 EDT 2025
Tue Jul 01 03:17:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords epithelial cells
Ulcerative Colitis
SUCNR1
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c502t-28e8765440f895c57d77313ad516f3057aa3c1d0e61ed10224764ce3121f7ce33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9675-2423
0000-0002-4278-2835
0000-0002-2007-8716
0000-0002-9775-3169
0000-0002-7924-9962
OpenAccessLink https://doaj.org/article/03c4bdcc8e124ca5bb633d4ac1d4324f
PMID 35327334
PQID 2642347341
PQPubID 2032426
ParticipantIDs doaj_primary_oai_doaj_org_article_03c4bdcc8e124ca5bb633d4ac1d4324f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8945150
proquest_miscellaneous_2644021192
proquest_journals_2642347341
pubmed_primary_35327334
crossref_primary_10_3390_biomedicines10030532
crossref_citationtrail_10_3390_biomedicines10030532
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220224
PublicationDateYYYYMMDD 2022-02-24
PublicationDate_xml – month: 2
  year: 2022
  text: 20220224
  day: 24
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Biomedicines
PublicationTitleAlternate Biomedicines
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Ostvik (ref_1) 2020; 14
Khatri (ref_7) 2021; 35
Bush (ref_48) 2020; 8
Groslambert (ref_9) 2018; 11
ref_11
Santana (ref_38) 2016; 18
Obermeier (ref_37) 1999; 116
ref_53
Salvador (ref_26) 2019; 12
Zambetti (ref_21) 2014; 233
Hirota (ref_17) 2011; 17
Donovan (ref_20) 2020; 108
Velcicky (ref_27) 2020; 63
Patel (ref_12) 2017; 23
Allen (ref_40) 2009; 30
Mu (ref_42) 2017; 8
Ananth (ref_44) 2011; 52
Trauelsen (ref_32) 2017; 6
Shao (ref_13) 2019; 42
Allen (ref_19) 2010; 207
Zhen (ref_8) 2019; 10
Li (ref_28) 2020; 34
McCreath (ref_34) 2015; 64
Calatayud (ref_35) 2016; 9
MacFarlane (ref_22) 2020; 93
Itani (ref_16) 2016; 6
Robben (ref_46) 2009; 76
Mills (ref_24) 2014; 24
Fiocchi (ref_6) 2016; 13
Zaki (ref_18) 2010; 32
Hollander (ref_25) 2001; 44
Lu (ref_52) 2018; 9
Guo (ref_23) 2020; 35
ref_36
Fukata (ref_2) 2013; 6
Krzak (ref_29) 2021; 42
Man (ref_10) 2015; 265
ref_39
Bauer (ref_15) 2010; 59
Saraiva (ref_50) 2018; 32
Regairaz (ref_51) 2017; 72
Banerjee (ref_47) 2020; 159
Zhang (ref_14) 2014; 7
Yeretssian (ref_41) 2010; 32
Li (ref_43) 2014; 20
Robben (ref_31) 2017; 60
ref_45
Ghouri (ref_5) 2020; 26
Sarret (ref_30) 2016; 213
ref_3
Keiran (ref_33) 2019; 20
ref_49
Ng (ref_4) 2017; 390
References_xml – ident: ref_45
  doi: 10.1371/journal.pone.0119179
– volume: 10
  start-page: 276
  year: 2019
  ident: ref_8
  article-title: NLRP3 Inflammasome and Inflammatory Bowel Disease
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.00276
– volume: 12
  start-page: 178
  year: 2019
  ident: ref_26
  article-title: Succinate receptor mediates intestinal inflammation and fibrosis
  publication-title: Mucosal. Immunol.
  doi: 10.1038/s41385-018-0087-3
– volume: 93
  start-page: 528
  year: 2020
  ident: ref_22
  article-title: A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma
  publication-title: Clin. Endocrinol.
  doi: 10.1111/cen.14289
– ident: ref_11
  doi: 10.3390/cells9071647
– volume: 18
  start-page: 93
  year: 2016
  ident: ref_38
  article-title: Is the inflammasome relevant for epithelial cell function?
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2015.10.007
– volume: 20
  start-page: 581
  year: 2019
  ident: ref_33
  article-title: SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-019-0372-7
– volume: 233
  start-page: 321
  year: 2014
  ident: ref_21
  article-title: NLRPs, microbiota, and gut homeostasis: Unravelling the connection
  publication-title: J. Pathol.
  doi: 10.1002/path.4357
– volume: 35
  start-page: e21439
  year: 2021
  ident: ref_7
  article-title: Therapeutic implications of inflammasome in inflammatory bowel disease
  publication-title: FASEB J.
  doi: 10.1096/fj.202002622R
– volume: 32
  start-page: 6550
  year: 2018
  ident: ref_50
  article-title: Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes
  publication-title: FASEB J.
  doi: 10.1096/fj.201800285
– volume: 9
  start-page: 672
  year: 2018
  ident: ref_52
  article-title: Succinate induces aberrant mitochondrial fission in cardiomyocytes through GPR91 signaling
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-018-0708-5
– volume: 52
  start-page: 3751
  year: 2011
  ident: ref_44
  article-title: Expression and iron-dependent regulation of succinate receptor GPR91 in retinal pigment epithelium
  publication-title: Investig. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.10-6722
– volume: 30
  start-page: 556
  year: 2009
  ident: ref_40
  article-title: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.02.005
– volume: 6
  start-page: 451
  year: 2013
  ident: ref_2
  article-title: The role of pattern recognition receptors in intestinal inflammation
  publication-title: Mucosal. Immunol.
  doi: 10.1038/mi.2013.13
– volume: 13
  start-page: 13
  year: 2016
  ident: ref_6
  article-title: Immunopathogenesis of IBD: Current state of the art
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/nrgastro.2015.186
– volume: 24
  start-page: 313
  year: 2014
  ident: ref_24
  article-title: Succinate: A metabolic signal in inflammation
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2013.11.008
– volume: 6
  start-page: 39075
  year: 2016
  ident: ref_16
  article-title: NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: A possible role in ulcerative colitis
  publication-title: Sci. Rep.
  doi: 10.1038/srep39075
– volume: 32
  start-page: 367
  year: 2010
  ident: ref_41
  article-title: Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.02.012
– volume: 14
  start-page: 920
  year: 2020
  ident: ref_1
  article-title: Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn’s Disease
  publication-title: J. Crohn’s Colitis
  doi: 10.1093/ecco-jcc/jjaa022
– volume: 159
  start-page: 2101
  year: 2020
  ident: ref_47
  article-title: Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.08.029
– volume: 20
  start-page: 1109
  year: 2014
  ident: ref_43
  article-title: ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes
  publication-title: Mol. Vis.
– volume: 42
  start-page: 45
  year: 2021
  ident: ref_29
  article-title: Succinate Receptor 1: An Emerging Regulator of Myeloid Cell Function in Inflammation
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2020.11.004
– volume: 11
  start-page: 359
  year: 2018
  ident: ref_9
  article-title: Spotlight on the NLRP3 inflammasome pathway
  publication-title: J. Inflamm. Res.
  doi: 10.2147/JIR.S141220
– volume: 44
  start-page: 1540
  year: 2001
  ident: ref_25
  article-title: Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: Implications for targeting of therapeutic genes to the inflamed joint
  publication-title: Arthritis Rheum.
  doi: 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7
– volume: 6
  start-page: 1585
  year: 2017
  ident: ref_32
  article-title: Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91
  publication-title: Mol. Metab.
  doi: 10.1016/j.molmet.2017.09.005
– ident: ref_49
  doi: 10.3390/cancers13071653
– ident: ref_36
  doi: 10.3390/cells8091078
– volume: 34
  start-page: 13091
  year: 2020
  ident: ref_28
  article-title: GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses
  publication-title: FASEB J.
  doi: 10.1096/fj.202001037R
– ident: ref_53
  doi: 10.3390/cells9051104
– volume: 8
  start-page: 13174
  year: 2017
  ident: ref_42
  article-title: Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14485
– ident: ref_39
  doi: 10.1371/journal.pone.0074010
– volume: 32
  start-page: 379
  year: 2010
  ident: ref_18
  article-title: The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.03.003
– volume: 207
  start-page: 1045
  year: 2010
  ident: ref_19
  article-title: The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20100050
– volume: 265
  start-page: 6
  year: 2015
  ident: ref_10
  article-title: Regulation of inflammasome activation
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.12296
– volume: 213
  start-page: 1655
  year: 2016
  ident: ref_30
  article-title: GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20160061
– volume: 390
  start-page: 2769
  year: 2017
  ident: ref_4
  article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32448-0
– volume: 23
  start-page: 165
  year: 2017
  ident: ref_12
  article-title: Inflammasome Priming in Sterile Inflammatory Disease
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2016.12.007
– volume: 59
  start-page: 1192
  year: 2010
  ident: ref_15
  article-title: Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
  publication-title: Gut
  doi: 10.1136/gut.2009.197822
– volume: 116
  start-page: 238
  year: 1999
  ident: ref_37
  article-title: Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice
  publication-title: Clin. Exp. Immunol.
  doi: 10.1046/j.1365-2249.1999.00878.x
– volume: 35
  start-page: 36
  year: 2020
  ident: ref_23
  article-title: Multifaceted Actions of Succinate as a Signaling Transmitter Vary with Its Cellular Locations
  publication-title: Endocrinol. Metab.
  doi: 10.3803/EnM.2020.35.1.36
– volume: 76
  start-page: 1258
  year: 2009
  ident: ref_46
  article-title: Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells
  publication-title: Kidney Int.
  doi: 10.1038/ki.2009.360
– volume: 64
  start-page: 1154
  year: 2015
  ident: ref_34
  article-title: Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity
  publication-title: Diabetes
  doi: 10.2337/db14-0346
– volume: 72
  start-page: 444
  year: 2017
  ident: ref_51
  article-title: GPR91 deficiency exacerbates allergic contact dermatitis while reducing arthritic disease in mice
  publication-title: Allergy
  doi: 10.1111/all.13005
– volume: 42
  start-page: 1147
  year: 2019
  ident: ref_13
  article-title: Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation
  publication-title: Inflammation
  doi: 10.1007/s10753-019-01008-y
– volume: 7
  start-page: 1139
  year: 2014
  ident: ref_14
  article-title: Inflammasome activation has an important role in the development of spontaneous colitis
  publication-title: Mucosal. Immunol.
  doi: 10.1038/mi.2014.1
– volume: 108
  start-page: 925
  year: 2020
  ident: ref_20
  article-title: The role of the microbiome and the NLRP3 inflammasome in the gut and lung
  publication-title: J. Leukoc. Biol.
  doi: 10.1002/JLB.3MR0720-472RR
– volume: 17
  start-page: 1359
  year: 2011
  ident: ref_17
  article-title: NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
  publication-title: Inflamm. Bowel. Dis.
  doi: 10.1002/ibd.21478
– ident: ref_3
  doi: 10.3390/proteomes6020017
– volume: 60
  start-page: 1304
  year: 2017
  ident: ref_31
  article-title: SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-017-4261-z
– volume: 8
  start-page: 661
  year: 2020
  ident: ref_48
  article-title: Species-Specificity of Transcriptional Regulation and the Response to Lipopolysaccharide in Mammalian Macrophages
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2020.00661
– volume: 9
  start-page: 986
  year: 2016
  ident: ref_35
  article-title: The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD
  publication-title: Mucosal. Immunol.
  doi: 10.1038/mi.2015.123
– volume: 63
  start-page: 9856
  year: 2020
  ident: ref_27
  article-title: Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.0c01020
– volume: 26
  start-page: 3998
  year: 2020
  ident: ref_5
  article-title: Secondary causes of inflammatory bowel diseases
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v26.i28.3998
SSID ssj0000913814
Score 2.247668
Snippet Intestinal epithelial cells (IECs) constitute a defensive physical barrier in mucosal tissues and their disruption is involved in the etiopathogenesis of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 532
SubjectTerms Body fat
Cardiomyocytes
Dendritic cells
Epithelial cells
Experiments
Homeostasis
Immune system
Inflammasomes
Inflammatory bowel disease
Inflammatory bowel diseases
Intestine
Lipopolysaccharides
Metabolic pathways
Microbiota
Mucosa
Pathogens
Protein expression
Proteins
siRNA
SUCNR1
Ulcerative Colitis
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fa9swEBZb-7I9lO63u25osFdRy5IsZy-jDSndoKFkC_TNyLLUFTw7q9P_f3ey4jalbE8BWzFn3530nXT3HSGfrZqoinvPIJwwTGrBWWVMwVJjU1UZn_mQ8n8-z8-W8vuluowbbn1Mq9zMiWGirjuLe-RHsHBnAp4l-dfVH4Zdo_B0NbbQeEp2YQouIPjaPZnNLxbjLguyXhZcDjVzAuL7o6GqPZxa9zwgaJFtrUmBuv8xvPkwbfLeOnS6T_YigKTHg8ZfkCeufUme36MVfEXWP5bT-YLT89CGw_UUQB69CP27riimddHOh2vfWg8G8dv0ICy9biluD4LL4_NnKyzWaMA66dQ1Tf-FLrASHW0ERy4b6wbOcDoNGXT9a7I8nf2cnrHYXYFZlWZrlhUOZkIlZeqLibJK1xo0JUyteO7hs2hjhOV16nLu6kA8p3NpneAZ9xp-xRuy03ate0do6lwOUMHU3kHAJfnEiNx5BWDDSG6dTojYfN_SRupx7IDRlBCCoFbKx7SSEDb-azVQb_xn_AmqbhyLxNnhQndzVUY_LFNhZVVbWzgANtaoqsqFqKWBN0VuQp-Qw43iy-jNfXlnewn5NN4GP8TDFdO67jaMgVCcA2BOyNvBTkZJBEinhZAJ0VsWtCXq9p32-lfg-i4mEhBnevBvsd6TZxmWZWCpvTwkO-ubW_cBwNK6-hg94i8ToBfX
  priority: 102
  providerName: ProQuest
Title SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis
URI https://www.ncbi.nlm.nih.gov/pubmed/35327334
https://www.proquest.com/docview/2642347341
https://www.proquest.com/docview/2644021192
https://pubmed.ncbi.nlm.nih.gov/PMC8945150
https://doaj.org/article/03c4bdcc8e124ca5bb633d4ac1d4324f
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9wwDBaje9kexn4vW1c82GtoHNtxsrf1uNINepTbDvoWHEfeCmmuLNf_f5KTHnej0Jc9BRInKJZsfUqkTwCfvalMI0NIKZxwqbZKpo1zZZo5n5nGhTzElP_zRXG20t8vzeVOqy_OCRvpgceJO86U103rfYnkibwzTVMo1WrnZctkcoF3X_J5O8FU3IMrSa5Ij7VyiuL647GaPf6tHmREzirf80WRsv8-nPlvuuSO_zl9Ds8m4Ci-jgK_gEfYv4SnO3SCr2DzYzVbLKU4j-03cBAE7sRF7Nv1S3A6l1iHeO5bH8gQrt1AwoqrXvBnQVrq_Pz5DRdpdGSVYoZdN3wRS65AZ9vgkavO48gVLmYxc254DavT-c_ZWTp1VUi9yfJNmpdIO6DROgtlZbyxrSUNKdcaWQSaFuucosnNsJDYRsI5W2iPSuYyWDqqN3DQr3t8ByJDLAgiuDYgBVpaVk4VGAyBDKelR5uAupvf2k-U49z5oqsp9GCt1PdpJYF0e9fNSLnxwPgTVt12LBNmxxNkRvVkRvVDZpTA4Z3i62kVDzWBxVyR_WqZwKftZVp__FPF9bi-jWMoBJcElBN4O9rJVhJF0lmldAJ2z4L2RN2_0l_9jhzfZaUJaWbv_8e7fYAnORdtcCG-PoSDzZ9b_EhQatMcweOT-eJieRRXz1_A1SGa
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4a3QPwgLgTGGAkeIwWx3aSIiHESqeWrdVUVmlvwXHsMSkkZemE-FP8Ro6dCyua4GlPkRLHOsm5-Dv2uQC8VmIoMmqMj-6E9HnMqJ9JmfiBVIHIpAmNC_mfzaPJkn86ESdb8KvLhbFhlZ1NdIY6r5TdI9_FhTtkOBen71fffds1yp6udi00GrE40D9_oMtWv5t-RP6-CcP98fFo4rddBXwlgnDth4lGCyA4D0wyFErEeYwUMpkLGhmU_lhKpmge6Ijq3BVciyOuNKMhNTFeGc57A7Y5Q1dmANt74_nRot_VsVU2E8qbHD3GhsFuk0XvTslr6hA7CzfWQNcq4Cp8-3eY5qV1b_8u3GkBK_nQSNg92NLlfbh9qYzhA1h_Xo7mC0pmru2HrgmCSnLk-oWdEhtGRirj7k1LgwL4TdZILDkrid2ORBNj5x-vbHJIgdpARroo6rdkYTPfrUzakctC6aZGORm5iL36ISyv5b8_gkFZlfoJkEDrCKGJzI1GB4_ToWSRNgLBjeRU6dgD1v3fVLWlzm3HjSJFl8dyJb2KKx74_VurptTHf8bvWdb1Y22hbnejOj9NW71PA6Z4liuVaARSSoosixjLucQvtbUQjQc7HePT1nrU6R9Z9-BV_xj13h7myFJXF24Muv4UAboHjxs56SlhSF3MGPcg3pCgDVI3n5RnX11t8WTIEeEGT_9N1ku4OTmeHaaH0_nBM7gV2pQQm-bPd2CwPr_QzxGorbMXrXYQ-HLdCvkbkdtSgg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJyF4QHxTGGAkeIxqx3Y-kBBiXauVsaoqVNpb5jj2mNSl3dIJ8a_x13HnpGFFEzztKVLiWJfch-_su98R8taoVOXcuQDCCR3IWPAg1zoJmDZM5dqFzqf8H46j_Zn8fKSOtsivdS0MplWubaI31MXC4B55DxbuUMBckvdckxYx2Rt-XJ4H2EEKT1rX7TRqETmwP39A-FZ9GO0Br9-F4XDwrb8fNB0GAqNYuArCxII1UFIyl6TKqLiIgVqhC8UjB5oQay0ML5iNuC08-FocSWMFD7mL4Spg3ltkO4aoiHXI9u5gPJm2OzyIuJlwWdfrCZGyXl1R70_MK-69dxFurIe-bcB1vu7fKZtX1sDhfXKvcV7pp1raHpAtWz4kd69AGj4iq6-z_njK6aFvAWIrCg4mnfjeYScUU8rowvl7o9KBMJ7pCoilpyXFrUkwNzj_YImFInPQDNq383n1nk6xCh7lE0fO5sbWeOW077P3qsdkdiP__QnplIvSPiOUWRuBm6ILZyHYkzzVIrJOgaOjJTc27hKx_r-ZaWDPsfvGPIPwB7mSXceVLgnat5Y17Md_xu8i69qxCNrtbywuTrLGBmRMGJkXxiQWnCqjVZ5HQhRSw5ciLqLrkp0147PGklTZH7nvkjftY7ABeLCjS7u49GMkQ6g-oONpLSctJQKoi4WQXRJvSNAGqZtPytPvHmc8SSV4u-z5v8l6TW6DImZfRuODF-ROiNUhWPEvd0hndXFpX4LPtspfNcpByfFN6-NvOg1Wtw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SUCNR1+Mediates+the+Priming+Step+of+the+Inflammasome+in+Intestinal+Epithelial+Cells%3A+Relevance+in+Ulcerative+Colitis&rft.jtitle=Biomedicines&rft.au=Bauset%2C+Cristina&rft.au=Lis-Lopez%2C+Lluis&rft.au=Coll%2C+Sandra&rft.au=Gisbert-Ferr%C3%A1ndiz%2C+Laura&rft.date=2022-02-24&rft.issn=2227-9059&rft.eissn=2227-9059&rft.volume=10&rft.issue=3&rft.spage=532&rft_id=info:doi/10.3390%2Fbiomedicines10030532&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_biomedicines10030532
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2227-9059&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2227-9059&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2227-9059&client=summon